{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T10:45:02Z","timestamp":1787309102719,"version":"build-2736575974"},"reference-count":24,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2001,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>\u03b2-Lactams have been considered ineffective against organisms growing inside mammalian cells because of their poor penetration into cells. However, cefixime has been shown to be clinically effective against typhoid fever. The probable mechanism of therapeutic effectiveness of cefixime against typhoid fever was investigated using<jats:italic>Salmonella enterica<\/jats:italic>serovar Typhimurium instead of<jats:italic>S. enterica<\/jats:italic>serovar Typhi both in a cellular and in a mouse infection model. Cefixime was able to inhibit the growth of serovar Typhimurium inhabiting monocyte-derived THP-1 cells. Elongation of serovar Typhimurium in THP-1 cells was observed microscopically. Apparent morphological changes of serovar Typhimurium in THP-1 cells were also observed by electron microscopy. The concentration of cefixime inside THP-1 cells was almost half (46 to 48%) of the concentration outside the cells when serovar Typhimurium coexisted in the solution. The length of time after oral dosing (8 mg\/kg) that cefixime was present\u2014calculated from levels in serum\u2014at a concentration above the MIC at which 90% of the serovar Typhi organisms inside human cells were inhibited was presumed to be more than 12 h. Cefixime also showed excellent activity in the mouse systemic and oral infection models based on infections caused by serovar Typhimurium. It is concluded that a fair amount of cefixime can enter mammalian cells and inhibit the growth of bacteria inside cells when the bacteria are sensitive enough to cefixime, as are serovars Typhimurium and Typhi.<\/jats:p>","DOI":"10.1128\/aac.45.9.2450-2454.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T05:56:57Z","timestamp":1027749417000},"page":"2450-2454","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":17,"title":["Mechanism of Therapeutic Effectiveness of Cefixime against Typhoid Fever"],"prefix":"10.1128","volume":"45","author":[{"given":"Yoshimi","family":"Matsumoto","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Ikemoto","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Wakai","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Ikeda","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Tawara","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka,1and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Nagasaki University, Nagasaki,2Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4269\/ajtmh.1995.53.306","article-title":"Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella.","volume":"53","author":"Alam M. N.","year":"1995","unstructured":"Alam M. N. Haq S. A. Das K. K. Baral P. K. Mazid M. N. Siddique R. U. Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella. Am. J. Trop. Med. Hyg. 53 1995 306 311","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1742-1241.1997.tb09617.x","article-title":"A clinical comparison of typhoid fever caused by susceptible and multidrug-resistant strains of Salmonella typhi.","volume":"51","author":"Alsoub H.","year":"1997","unstructured":"Alsoub H. Uwaydah A. K. Mater I. Zebeib M. Elhag K. M. A clinical comparison of typhoid fever caused by susceptible and multidrug-resistant strains of Salmonella typhi. Br. J. Clin. Pract. 51 1997 8 10","journal-title":"Br. J. Clin. Pract."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/00006454-199411000-00010","article-title":"Therapy of multidrug-resistant typhoid fever with oral cefixime vs. intravenous ceftriaxone.","volume":"13","author":"Bhutta Z. A.","year":"1994","unstructured":"Bhutta Z. A. Khan J. A. Molla A. M. Therapy of multidrug-resistant typhoid fever with oral cefixime vs. intravenous ceftriaxone. Pediatr. Infect. Dis. J. 13 1994 990 994","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_5_2","unstructured":"Bhutta Z. A. A randomized controlled trial of oral cefixime in typhoid fever during childhood: a dose finding study. Proceedings of the 4th International Symposium on Typhoid Fever and Other Salmonellosis Taiwan. 1999 Torre Lazur McCann Inc. Osaka Japan"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.38.4.442"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/00006454-198710000-00035","article-title":"Pharmacokinetic profile of cefixime in man.","volume":"6","author":"Faulkner R. D.","year":"1987","unstructured":"Faulkner R. D. Yakobi A. Barone J. S. Kaplan S. A. Silber B. M. Pharmacokinetic profile of cefixime in man. Pediatr. Infect. Dis. J. 6 1987 963 970","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/tropej\/41.6.364","article-title":"Short course chemotherapy with cefixime in children with multidrug-resistant Salmonella typhi septicaemia.","volume":"41","author":"Girgis N. I.","year":"1995","unstructured":"Girgis N. I. Tribble D. R. Sultan Y. Farid Z. Short course chemotherapy with cefixime in children with multidrug-resistant Salmonella typhi septicaemia. J. Trop. Pediatr. 41 1995 364 365","journal-title":"J. Trop. Pediatr."},{"key":"e_1_3_2_9_2","first-page":"47","article-title":"Cefixime in treatment of enteric fever in children.","volume":"19","author":"Girgis N. I.","year":"1993","unstructured":"Girgis N. I. Kilpatrick M. E. Farid Z. Sultan Y. Podgore J. K. Cefixime in treatment of enteric fever in children. Drugs Exp. Clin. Res. 19 1993 47 49","journal-title":"Drugs Exp. Clin. Res."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00006454-199507000-00010","article-title":"Comparison of the efficacy, safety, and cost of cefixime, ceftriaxone, and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children.","volume":"14","author":"Girgis N. I.","year":"1995","unstructured":"Girgis N. I. Sultan Y. Hammad O. Farid Z. Comparison of the efficacy, safety, and cost of cefixime, ceftriaxone, and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children. Pediatr. Infect. Dis. J. 14 1995 603 605","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00249-Z"},{"key":"e_1_3_2_12_2","first-page":"429","article-title":"Antibiotic uptake by alveolar macrophages.","volume":"95","author":"Johnson J. D.","year":"1980","unstructured":"Johnson J. D. Hand W. L. Francis J. B. King-Thompson N. Corwin R. W. Antibiotic uptake by alveolar macrophages. J. Lab. Clin. Med. 95 1980 429 439","journal-title":"J. Lab. Clin. Med."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.12.1904"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s101560050030","article-title":"Antibacterial activity of cefixime against Salmonella typhi and applicability of Etest.","volume":"5","author":"Matsumoto Y.","year":"1999","unstructured":"Matsumoto Y. Ikemoto A. Tawara S. Antibacterial activity of cefixime against Salmonella typhi and applicability of Etest. J. Infect. Chemother. 5 1999 176 179","journal-title":"J. Infect. Chemother."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/00007611-199712000-00008","article-title":"Cefixime: an oral option for the treatment of multidrug-resistant enteric fever in children.","volume":"90","author":"Memon I. A.","year":"1997","unstructured":"Memon I. A. Billoo F. A. G. Memon H. I. Cefixime: an oral option for the treatment of multidrug-resistant enteric fever in children. South. Med. J. 90 1997 1204 1207","journal-title":"South. Med. J."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/00034983.1995.11812984","article-title":"The prevalence and clinical features of multi-drug resistant Salmonella typhi infections in Bauchistan, Pakistan.","volume":"89","author":"Mirza S. H.","year":"1995","unstructured":"Mirza S. H. Beeching N. J. Hart C. A. The prevalence and clinical features of multi-drug resistant Salmonella typhi infections in Bauchistan, Pakistan. Ann. Trop. Med. Parasitol. 89 1995 515 519","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0140-6736(05)79356-9","article-title":"Quinolone-resistant Salmonella typhi in Vietnam.","volume":"351","author":"Parry C.","year":"1998","unstructured":"Parry C. Quinolone-resistant Salmonella typhi in Vietnam. Lancet 351 1998 1289","journal-title":"Lancet"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00006454-199903000-00007","article-title":"A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children.","volume":"18","author":"Phuong C. X. T.","year":"1999","unstructured":"Phuong C. X. T. Kneen R. Anh N. T. Luat T. D. White N. J. Parry C. M. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. Pediatr. Infect. Dis. J. 18 1999 245 248","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_19_2","first-page":"163","article-title":"A comparative study of cefixime and chloramphenicol in children with typhoid fever.","volume":"48","author":"Rabbani M. W.","year":"1998","unstructured":"Rabbani M. W. Iqbal I. Malik M. S. A comparative study of cefixime and chloramphenicol in children with typhoid fever. J. Pak. Med. Assoc. 48 1998 163 164","journal-title":"J. Pak. Med. Assoc."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4269\/ajtmh.1993.48.108","article-title":"Emergence of multidrug-resistant Salmonella typhi in rural southern India.","volume":"48","author":"Rao P. S.","year":"1993","unstructured":"Rao P. S. Rajashekar V. Varghese G. K. Shivananda P. G. Emergence of multidrug-resistant Salmonella typhi in rural southern India. Am. J. Trop. Med. Hyg. 48 1993 108 111","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1442-200X.1997.tb03585.x","article-title":"Ofloxacin versus co-trimoxazole in the treatment of typhoid fever in children.","volume":"39","author":"Se\u00e7meer G.","year":"1997","unstructured":"Se\u00e7meer G. Kanra G. Figen G. Akan \u00d6. Ceyhan M. Ecevit Z. Ofloxacin versus co-trimoxazole in the treatment of typhoid fever in children. Acta Paediatr. Jpn. 39 1997 218 221","journal-title":"Acta Paediatr. Jpn."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"790","DOI":"10.7164\/antibiotics.37.790","article-title":"Mechanism of action of the new orally active cephalosporin FK027.","volume":"37","author":"Shigi Y.","year":"1984","unstructured":"Shigi Y. Matsumoto Y. Kaizu M. Fujishita Y. Kojo H. Mechanism of action of the new orally active cephalosporin FK027. J. Antibiot. 37 1984 790 796","journal-title":"J. Antibiot."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.4.958"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/516128"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/36.1.23","article-title":"Fluoroquinolones and bacterial enteritis, when and for whom?","volume":"36","author":"Wistrom J.","year":"1995","unstructured":"Wistrom J. Norrby S. R. Fluoroquinolones and bacterial enteritis, when and for whom? J. Antimicrob. Chemother. 36 1995 23 39","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.45.9.2450-2454.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.45.9.2450-2454.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T18:51:39Z","timestamp":1704480699000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.45.9.2450-2454.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1128\/AAC.45.9.2450-2454.2001"],"URL":"https:\/\/doi.org\/10.1128\/aac.45.9.2450-2454.2001","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]},"assertion":[{"value":"2000-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-05-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}